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Abstract
Improvements in colorectal cancer (CRC) detection and treatment have led to greater numbers of CRC survivors, for whom there is limited
evidence on which to provide dietary guidelines to improve survival outcomes. Higher intake of red and processed meat and lower intake of
ﬁbre are associated with greater risk of developing CRC, but there is limited evidence regarding associations with survival after CRC diagnosis.
Among 3789 CRC cases in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort, pre-diagnostic consumption of red
meat, processed meat, poultry and dietary ﬁbre was examined in relation to CRC-speciﬁc mortality (n 1008) and all-cause mortality (n 1262)
using multivariable Cox regression models, adjusted for CRC risk factors. Pre-diagnostic red meat, processed meat or ﬁbre intakes (deﬁned as
quartiles and continuous grams per day) were not associated with CRC-speciﬁc or all-cause mortality among CRC survivors; however, a marginal
trend across quartiles of processed meat in relation to CRC mortality was detected (P 0·053). Pre-diagnostic poultry intake was inversely
associated with all-cause mortality among women (hazard ratio (HR)/20g/d 0·92; 95% CI 0·84, 1·00), but not among men (HR 1·00; 95% CI 0·91,
1·09) (Pfor heterogeneity= 0·10). Pre-diagnostic intake of red meat or ﬁbre is not associated with CRC survival in the EPIC cohort. There is suggestive
evidence of an association between poultry intake and all-cause mortality among female CRC survivors and between processed meat intake and
CRC-speciﬁc mortality; however, further research using post-diagnostic dietary data is required to conﬁrm this relationship.
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Diet is thought to play a key role in cancer prevention, with more
than half of colorectal cancers (CRC) potentially preventable
through diet and lifestyle modiﬁcations(1). However, the role of
diet on CRC survival is unclear. With an estimated 244 000 CRC
patients in the UK, this is an urgent area of research. There are a
number of plausible mechanisms to link diet to CRC, including
formation of N-nitroso compounds(2), anti-inﬂammatory
effects(3), contributions to DNA synthesis and methylation(4),
inhibition of cancer cell proliferation(5,6), binding to free fatty
acids and bile acids(7), production of anticancer SCFA(8), insulin
lowering(9) and metabolic activity attributed to adiposity(10).
In particular, convincing evidence has been presented for foods
containing dietary ﬁbre (lower CRC risk) and for red and pro-
cessed meat (higher CRC risk)(11); these pathways may also be
relevant for CRC recurrence and survival outcomes. CRC patients
frequently request dietary recommendations(12), but there is
insufﬁcient evidence at present to provide guidance(13). This is
an increasingly necessary area of research as CRC survival rates
have improved because of earlier detection and advances in
treatment in many Western countries(14,15); between 1989 and
2011, mortality has decreased among European CRC patients by
13% in men and 27% in women(16).
At present, the few available studies on CRC survival and
consumption of meat and ﬁbre have yielded inconclusive
ﬁndings. In the Cancer Prevention Study II, post-diagnostic
intake of red and processed meat was not associated with
survival among CRC patients(17). However, pre-diagnostic
intake of red and processed meat was associated with greater
all-cause mortality, and those with high intake of red and
processed meat during both pre- and post-diagnostic dietary
assessments were at greater risk of CRC-speciﬁc mortality(17). In
a smaller US study, post-diagnosis red meat intake was asso-
ciated with higher mortality risk, but only among those with
familial CRC(18). Results for post-diagnostic ﬁbre intake and CRC
survival are similarly mixed. Among Mormons in Utah (USA),
higher ﬁbre intake was associated with poorer mortality
outcomes(19), whereas another US study(18) yielded null results.
Pre-diagnostic ﬁbre intake was also unrelated to survival
outcomes among CRC patients in studies from France(20) and
Scandinavia(21). However, many of the aforementioned studies
had relatively small sample sizes (<500 CRC cases(18,19,21)) and
may have been underpowered to detect statistically signiﬁcant
associations. Drawing on the large European Prospective
Investigation into Cancer and Nutrition (EPIC) cohort, the
objective of the present analysis was to further characterise the
role of pre-diagnostic meat and ﬁbre intakes on survival among
CRC cases, with separate consideration for red meat, processed
meat and poultry.
Methods
Study population
EPIC is a multi-centre, prospective cohort study, which recrui-
ted 519 978 volunteers (mostly ages 25–70 years) from twenty-
three centres in ten countries (Sweden, Denmark, Norway, The
Netherlands, UK, France, Germany, Spain, Italy and Greece)
between 1992 and 2000. The study has been described in detail
previously(22,23). EPIC was approved by the Institutional Review
Board at the International Agency for Research on Cancer
(Lyon, France) and local ethics committees, and informed
consent was obtained from all participants.
Data collection and deﬁnitions
At baseline, participants reported dietary intake using country-
speciﬁc validated questionnaires. In most centres, a self-
administered FFQ was used to assess intake over the past
12 months (eighty-eight to 266 food items). A questionnaire plus
food record was used in Malmö, Sweden, and interviewer-
administered diet questionnaires were used in Greece, Spain and
Ragusa, Italy. For this analysis, red meat included beef, pork,
mutton/lamb, horse, goat; processed meat included all meat
products including ham, bacon, sausages and a small part of
minced meat in ready-to-eat products; and poultry included
chicken, hen, turkey, duck, goose, unclassiﬁed poultry and rabbit
(domestic). Dietary intake of ﬁbre was calculated from the stan-
dardised EPIC Nutrient Data Base(24). Questionnaires on educa-
tion, occupation, previous illnesses, alcohol and tobacco
consumption, and physical activity were also completed by par-
ticipants. Anthropometric variables were measured in most cen-
tres; as exceptions, self-reported data were used in France and
Norway, and in Oxford self-reported data were adjusted based on
measurements collected from a subset of participants(25).
Population cancer registries were used in Denmark, Italy, The
Netherlands, Norway, Spain, Sweden and the UK to identify
incident cancers. In France, Germany and Greece, cancer cases
were identiﬁed through active follow-up, directly through study
participants or next of kin, and conﬁrmed by a combination of
methods including health insurance records as well as cancer
and pathology registries. CRC cases were identiﬁed according to
the second edition of the International Classiﬁcation of
Diseases for Oncology (ICD-O), either as located in the colon
(C18.0–C18.7), rectum (C19 and C20) or overlapping/unspeci-
ﬁed (C18.8 and 18.9).
The date of CRC diagnosis was used as the start date of follow-
up for the present study. Participants were censored at date of
death, last date of contact or the date at which follow-up data
were considered to be complete at each study centre (between
June 2005 and June 2009). Loss to follow-up across all countries
was low (<2%). Harmonisation of tumour stage data was
required to combine TNM (Tumour, Node, Metastasis) classiﬁ-
cation classiﬁcation, Dukes’s classiﬁcation or centre-speciﬁc
classiﬁcation; this process has been described previously(26).
A total of 4701 CRC cases were identiﬁed. Cases excluded
from the present analysis were as follows: 426 cases diagnosed
with CRC after vital status censoring date, 172 cases with in situ
or metastatic tumour, 144 non-adenocarcinoma or tumour of
unknown morphology, twenty-one because of missing date of
death or diagnosis, eight missing cause of death, seventy-four
within the extreme ranking (top and bottom 1%) of the ratio
energy intake:energy requirement and sixty-seven with missing
data on diet. The ﬁnal sample included 3789 CRC cases (1603
men and 2186 women; 2383 colon cancer cases and 1406 rectal
cancer cases).
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Availability of data on tumour stage and grade varied
between centres: there were 970 participants with missing stage
data, including all participants from Malmö (n 353) and Oxford
(n 271), and there were 2080 participants with missing grade
data, including all participants from Denmark (n 705), Malmö
(n 353), Cambridge (n 270) and Oxford (n 271), as well as over
85% of participants from Umeå (n 155).
Mortality data were obtained at the regional or national level.
In Denmark, Italy, The Netherlands, Norway, Spain, Sweden
and the UK, vital status and the causes and dates of death were
ascertained by death indices, cancer registry records and
national health statistics. Active follow-up was adopted in
Germany, Greece and France. Causes of death were coded
according to the International Classiﬁcation of Diseases, 10th
Revision (ICD-10). Up to six qualiﬁers of the cause of death
were reviewed. Death from CRC was assigned based on the
underlying cause of death.
Statistical analysis
The primary end point in the present analysis was death due to
CRC (with other causes of death modelled as competing risks,
using SAS macro PSHREG(27)); the secondary end point was all-
cause mortality. The pre-diagnostic dietary exposures in the
present analysis, rescaled to reﬂect approximately 1 SD, were
ﬁbre (10 g/d), red meat (40 g/d), processed meat (30 g/d),
combined red and processed meat (50 g/d) and poultry (20 g/d);
separate models were built for each dietary exposure.
Sex-speciﬁc quartiles (Q) of the dietary variables were also
derived for analysis. Fibre was further analysed by source
(cereal, fruit and vegetable) as quartile and continuous grams
per day. Tests for trend across quartiles were conducted by
assigning participants the sex-speciﬁc median value per quartile.
The proportional hazards models used age at CRC diagnosis
and age at censoring as the underlying time variables, and the
models were stratiﬁed by country; two models are presented:
(i) a model that adjusts for age at diagnosis and sex and (ii) a
multivariable model adjusting for additional confounders.
Potentially confounding variables were selected on the basis of
possible associations with both the outcome and the dietary
exposures, and were entered into the model stepwise to deter-
mine whether they changed the association between dietary
exposure and mortality by 10% or more. The following variables
were identiﬁed for one or more of the dietary exposures under
study: education level (primary school, technical/professional
school, secondary school, longer education (including university
degree), not speciﬁed/missing), smoking status (current, former,
never, unknown), BMI (kg/m2, continuous), total energy intake
(kJ/d (kcal/d)), Ca intake (mg/d), folate intake (mg/d), alcohol
intake (g/d: 0, >0–6 (M)/>0–3 (W), >6–12 (M)/>3–12 (W),
>12–24, >24–60, >60), tumour grade (well differentiated, mod-
erately differentiated, poorly/undifferentiated, unknown),
tumour stage (localised (I), localised with invasion (II), metastatic
regional (III), metastatic distant (IV), unknown) and year of
diagnosis (continuous, calendar year). Adjustment for physical
activity (the Cambridge Index categories(28)) and cancer site
(colon v. rectum) did not change any associations by 10% or
more, and were therefore not included. The independent effect
of red meat, processed meat, poultry and ﬁbre was explored by
mutually adjusting for each other in an additional model. The
validity of the proportional hazards assumption was tested by
inclusion of time-varying covariates; there was no evidence of
deviation from proportionality.
Potential interactions with pre-diagnostic red meat, poultry,
processed meat and ﬁbre as continuous variables were tested for
education level (primary school, technical/professional/second-
ary school, longer education) smoking status (current, former,
never), BMI (<25, 25–30, >30 kg/m2), intake of total energy
(kJ/d (kcal/d)), Ca intake (mg/d), folate intake (mg/d), alcohol
intake (g/d: 0, >0–6 (M)/>0–3 (W), >6–24 (M)/>3–24 (W),
≥24), stage (I–III v. IV), age at diagnosis (<60, 60–69, ≥70
years), year of diagnosis (1992–1999, 2000–2004, 2005–2009),
median length of follow-up after CRC diagnosis (<3·3 v. ≥3·3
years) and median length of time between dietary assessment
and CRC diagnosis (<6·5 v. ≥ 6·5 years). The signiﬁcance of
interaction terms was assessed by likelihood ratio tests com-
paring nested models with and without the interaction terms.
A number of sensitivity analyses were conducted. Waist cir-
cumference was identiﬁed as a potential confounder, but was
examined in a supplementary model rather than the main
analysis because of a relatively high proportion of missing data
(n 566). In order to explore the potential inﬂuence of advanced
CRC, the main models were reanalysed (i) among participants
with stage I, II or III tumours and (ii) restricted to deaths
occurring more than 6 months after recruitment. The effect of
replacing red and processed meat with poultry was estimated
by substitution models, where total intake of red meat,
processed meat and poultry was held constant and an increase
in poultry intake represented an equal decrease in red and
processed meat intake(29).
Tumour stage data were missing for 25·6% of participants.
The inﬂuence of missing stage data was examined by three
ways: (i) creation of a separate ‘missing’ category for Malmö
and Oxford, (ii) exclusion of Oxford and Malmö and
(iii) imputation of missing values using SAS imputation com-
mand PROC MI. Stage was assumed to be missing at random,
and imputation was based on sex, age at CRC diagnosis, year of
diagnosis, tumour site, period between CRC diagnosis and
death or censoring and vital status as covariates (ﬁve iterations).
Results
Among 1603 men and 2186 women, there were 1008 deaths
due to CRC (1262 deaths from all causes). The average length of
follow-up since CRC diagnosis was 4·1 years. Baseline
characteristics according to low (Q1) and high (Q4) pre-
diagnostic intakes of red and processed meat, poultry and ﬁbre
are presented separately for men and women in Table 1. For
men and women, those in the highest quartile of red and
processed meat intake had relatively higher waist cir-
cumference measurements and included a larger proportion of
smokers and those with lower levels of education. In contrast,
those in the highest quartile of poultry intake had lower waist
circumference values than those in Q1. Among men, there was
a higher proportion of rectal cancers in Q4 for red and
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processed meat intake (47·4%) compared with Q1 (38·5%): the
corresponding distribution among women was less varied
(34·5 v. 31·5% for Q4 and Q1 of red and processed meat intake,
respectively).
In both the age-adjusted and multivariable analysis, there was
no evidence of an association between pre-diagnostic intakes of
red meat, poultry or ﬁbre and death due to CRC (Table 2).
For processed meat and CRC mortality, a marginally signiﬁcant
test for trend was detected across quartiles (P= 0·053, Table 2),
but no association was detected among the individual
quartiles or in the continuous analysis of grams per day.
The corresponding results for all-cause mortality were also null,
with the exception of a positive association in the highest
quartile of processed meat that was limited to the age- and
sex-adjusted model (hazard ratio (HR) 1·23; 95% CI 1·04, 1·46))
(Table 3).
Testing for interactions between the main dietary exposures
(modelled as continuous variables) and other covariates yielded
mostly null results (online Supplementary Table S1). A marginal
interaction between poultry intake (continuous g/d) and sex
was detected in relation to all-cause mortality (P value 0·10);
stratiﬁcation by sex revealed a signiﬁcant inverse association
among women (HR/20 g 0·92; 95% CI 0·84, 1·00) but not among
men (HR 1·00; 95% CI 0·91, 1·09) (online Supplementary
Table S2). For both CRC-speciﬁc and all-cause mortality, inter-
actions were detected between processed meat intake (30 g/d)
and folate intake (P values 0·016 and 0·06, respectively, online
Supplementary Table S1); however, the associations for pro-
cessed meat remained null when the sample was divided by
tertiles of folate intake. For CRC-speciﬁc mortality, a marginal
interaction was detected between poultry and BMI group
(P value 0·06); stratiﬁcation by BMI group yielded an inverse
relationship among overweight adults (HR/20 g 0·89; 95% CI
0·80, 1·00) but no associations among normal-weight (HR 0·99;
95% CI 0·87, 1·12) or obese adults (HR 1·10; 95% CI 0·95, 1·27)
(online Supplementary Table S1). There was no evidence of
interactions by length of follow-up or lag-time between dietary
assessment and CRC diagnosis. Owing to the large number of
Table 1. Demographic, anthropometric and lifestyle characteristics according to pre-diagnostic meat and fibre intakes among colorectal cancer cases in
European Prospective Investigation into Cancer and Nutrition
M W
Red and processed meat Fibre Poultry Red and processed meat Fibre Poultry
Q1 Q4 Q1 Q4 Q1 Q4 Q1 Q4 Q1 Q4 Q1 Q4
Age at recruitment (mean) 59·6 56·9 58·6 57·7 59·1 58·7 58·3 56·7 57·3 57·3 57·9 57·0
BMI (mean, kg/m2) 26·7 27·7 27·2 27·1 27·1 25·1 25·1 26·3 25·9 25·5 27·7 26·5
Waist circumference (mean) 95·9 98·8 97·5 97·2 97·4 81·2 80·8 85·0 83·0 82·7 98·8 85·1
Energy (mean, kJ/d) 8590 11 715 7895 11937 9456 10 560 7121 9100 6309 9782 7602 8703
Energy (mean, kcal/d) 2053 2800 1887 2853 2260 2524 1702 2175 1508 2338 1817 2080
Smokers (%)
Never 30·7 17·3 24·0 27·7 26·0 27·4 59·9 51·3 47·3 56·2 51·1 58·4
Former 47·6 46·6 45·2 43·7 49·3 42·5 26·9 22·6 24·9 25·5 28·3 21·1
Smoker 18·1 35·1 29·3 26·7 24·0 27·9 11·9 24·6 26·9 17·1 19·1 18·9
Unknown 3·5 1·0 1·5 2·0 0·8 2·2 1·3 1·5 0·9 1·1 1·5 1·6
Alcohol (%, g/d)
Non-drinker 12·6 4·5 8·1 7·4 9·8 8·0 17·7 13·3 19·8 13·8 15·4 17·8
>0–6 (M)/>0–3 (W) 30·5 11·8 20·5 22·8 26·0 15·9 38·8 28·3 30·7 35·6 34·9 26·5
>6–12 (M)/>3–12 (W) 18·1 13·5 15·2 17·5 15·3 12·9 24·6 29·6 22·8 29·4 24·0 27·4
>12–24 14·6 20·3 16·9 17·8 19·0 18·4 11·8 15·3 15·0 10·6 14·9 16·2
>24–60 21·7 36·3 25·8 28·9 21·8 35·8 7·1 12·6 10·1 10·1 9·9 11·1
>60 2·5 13·6 13·6 5·6 8·3 9·0 0·0 0·9 1·7 0·6 0·9 1·1
Education (%)
Primary school 37·8 43·1 46·0 38·3 42·0 45·5 28·0 35·2 37·8 29·1 30·3 40·3
Technical/professional 21·2 25·8 23·0 22·6 19·3 24·6 18·7 24·8 26·0 24·0 21·4 17·1
Secondary school 14·9 7·3 11·6 14·5 10·3 9·2 19·4 19·9 16·6 19·4 19·0 20·9
Longer education 20·2 21·6 17·9 20·1 26·3 17·4 23·0 16·8 15·1 20·5 21·8 16·5
Not specified 6·1 2·3 1·5 4·6 2·3 3·2 11·0 3·3 4·5 7·1 7·6 5·3
Tumour site (%)
Colon 61·5 52·6 60·4 55·6 58·3 55·2 68·5 65·5 68·2 65·0 64·3 67·7
Rectum 38·5 47·4 39·7 44·4 41·8 44·8 31·5 34·5 31·8 35·0 35·7 32·3
Tumour grade (%)
Well differentiated 4·3 4·0 3·5 3·1 3·5 6·7 9·3 12·0 8·0 9·5 10·2 12·5
Moderately differentiated 25·9 21·1 26·0 25·4 26·0 24·4 30·2 34·5 30·5 29·8 29·6 34·7
Poorly/undifferentiated 5·5 7·3 5·8 5·8 6·8 5·2 8·4 10·2 8·0 8·4 8·4 8·5
Unknown 64·2 67·7 64·7 65·7 63·8 63·7 52·1 43·3 53·5 52·3 51·9 44·3
Tumour stage (%)
Localised 18·6 21·8 18·7 19·0 15·3 20·7 14·2 17·0 18·5 16·6 15·6 16·2
Localised with invasion 13·6 18·6 16·4 18·3 17·3 15·9 16·8 19·9 14·6 18·1 14·7 19·1
Metastatic regional 28·2 26·6 25·3 27·4 17·5 27·9 23·9 33·6 25·8 29·8 23·4 30·9
Metastatic distant 7·1 11·8 10·6 13·5 8·3 8·7 8·0 11·1 11·0 10·4 8·7 9·1
Unknown 32·5 21·3 29·0 21·8 41·8 26·9 37·1 18·4 30·1 25·1 37·6 24·9
M, men; W, women; Q, quartile.
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Table 2. Colorectal cancer (CRC)-specific mortality in relation to pre-diagnostic fibre and meat intakes among CRC survivors in European Prospective Investigation into Cancer and Nutrition
(Hazard ratios (HR) and 95% confidence intervals)
Q1 Q2 Q3 Q4 Continuous
HR 95% CI HR 95% CI HR 95% CI HR 95% CI Pfor trend HR 95% CI
Fibre (mean, g/d) 14·5 19·5 24·1 31·2
Deaths (n) 259 249 265 235 Per 10 g
Model 1* 1·0 Ref. 0·94 0·79, 1·12 0·99 0·83, 1·18 0·87 0·73, 1·05 0·15 0·97 0·90, 1·06
Model 2† 1·0 Ref. 0·95 0·79, 1·15 1·04 0·85, 1·27 0·90 0·69, 1·17 0·13 1·00 0·87, 1·15
Red and processed meat (mean, g/d) 28·6 60·5 91·4 141·4
Deaths (n) 262 241 253 252 Per 50 g
Model 1* 1·0 Ref. 0·89 0·75, 1·07 0·96 0·80, 1·15 1·00 0·83, 1·20 0·65 0·98 0·86, 1·12
Model 2† 1·0 Ref. 0·90 0·75, 1·08 0·96 0·80, 1·16 1·00 0·81, 1·23 0·90 0·99 0·84, 1·15
Red meat (mean, g/d) 9·6 29·5 53·1 91·0
Deaths (n) 262 245 238 263 Per 40 g
Model 1* 1·0 Ref. 1·00 0·84, 1·20 0·92 0·76, 1·11 0·92 0·75, 1·13 0·30 0·97 0·88, 1·06
Model 2† 1·0 Ref. 0·91 0·76, 1·10 0·87 0·72, 1·06 0·93 0·75, 1·15 0·46 0·99 0·89, 1·10
Processed meat (mean, g/d) 5·9 19·6 35·3 66·2
Deaths (n) 255 251 254 248 Per 30 g
Model 1* 1·0 Ref. 1·04 0·87, 1·25 1·13 0·94, 1·36 1·17 0·94, 1·42 0·030 1·01 0·97, 1·06
Model 2† 1·0 Ref. 0·95 0·79, 1·15 1·07 0·88, 1·30 1·12 0·90, 1·39 0·053 1·00 0·95, 1·05
Poultry (mean, g/d) 0·6 9·3 18·1 41·5
Deaths (n) 251 259 260 238 Per 20 g
Model 1* 1·0 Ref. 1·00 0·84, 1·20 1·12 0·94, 1·35 0·93 0·77, 1·13 0·31 0·96 0·90, 1·03
Model 2† 1·0 Ref. 0·97 0·81, 1·16 1·13 0·94, 1·36 0·91 0·75, 1·10 0·17 0·96 0·89, 1·03
Q, quartile; Ref., referent values; M, men; W, women.
* Model 1: adjusted for age at diagnosis (1-year increments) and sex; stratified by country.
† Model 2: adjusted for age at diagnosis (1-year increments), sex, BMI (continuous), smoking status (current, former, never, unknown), tumour grade (well differentiated, moderately differentiated, poorly/undifferentiated, unknown), tumour
stage (I, II, III, IV, unknown), year of tumour diagnosis (continuous), energy intake (kJ/d (kcal/d)), Ca intake (mg/d), folate intake (mg/d), alcohol intake (g/d: 0, >0–6 (M)/>0–3 (W), >6–12 (M)/>3–12 (W), >12–24, >24–60, >60) and
education (primary school, technical/professional school, secondary school, longer education (including university, unknown)); stratified by country.
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interactions tested, signiﬁcant or marginally signiﬁcant results
may have been due to chance.
Further adjustment of the multivariable models to include
waist circumference did not alter the null associations detected,
nor did mutual adjustment for red meat, processed meat,
poultry and ﬁbre intakes. The effect of substituting poultry for
red and processed meat was not signiﬁcant for all-cause
mortality (HR/20 g 0·95; 95% CI 0·87, 1·03) or CRC-speciﬁc
death (HR/20 g 0·96; 95% CI 0·88, 1·06) (data not shown in
tables). Fibre from cereal, vegetable or fruit sources was not
associated with either CRC-speciﬁc or all-cause mortality in
multivariable models (online Supplementary Table S3 and S4);
these results remained null in further models where all ﬁbre
sources were examined simultaneously (data not shown).
Similarly, results were not altered by the exclusion of deaths
that occurred within 6 months of CRC diagnosis, limiting the
analysis to those with stage I, II or III tumours or exploring the
inﬂuence of missing stage data as described in the methods
section (data not shown).
Discussion
In the present analysis, pre-diagnostic intake of red meat or
ﬁbre was not associated with survival after CRC diagnosis.
Suggestive evidence was found for an inverse association
between poultry intake and mortality among women and for a
positive association between processed meat intake and risk of
CRC-speciﬁc mortality. The associations were unchanged
throughout a variety of sensitivity analyses and missing data
exploration. Overall, these results are in contrast to the relatively
consistent evidence regarding CRC prevention, where higher
ﬁbre and lower red or processed meat intakes are associated
with lower CRC risk(11). However, the number of studies avail-
able on meat and ﬁbre intakes and CRC survival is still con-
siderably smaller than that for CRC incidence; therefore, further
research is required to determine whether dietary recommen-
dations for CRC prevention can be extended to CRC survival.
The results of the present study can be compared with the
available evidence for meat and ﬁbre as individual exposures
and for dietary patterns that feature meat and ﬁbre as
predominant components. The null result for ﬁbre intake and
CRC survival in the present study is consistent with several
earlier studies(20,21,30). The predominantly Mormon population
among whom higher pre-diagnostic ﬁbre intake was associated
with poorer CRC survival has unique characteristics (prohibited
from alcohol, caffeine and tobacco), which render it less
comparable with the EPIC population(19). For meat intake, a
positive association in previous studies was limited to sub-
groups that we were not able to examine within EPIC: those
with a ﬁrst-degree relative with CRC(18) (post-diagnostic intake)
and those who had meat intakes consistently above the median
before and after diagnosis(17). In observational studies of post-
diagnostic dietary patterns, a Western pattern characterised by
high intake of red and processed meat was found to be
associated with poorer outcomes among CRC survivors(31–33).
The results for post-diagnostic dietary patterns are not entirely
consistent: one study found that the Alternative Healthy Eating
Table 3. All-cause mortality in relation to pre-diagnostic fibre and meat intakes among colorectal cancer survivors in European Prospective Investigation
into Cancer and Nutrition
(Hazard ratios (HR) and 95% confidence intervals)
Q1 Q2 Q3 Q4 Continuous
HR 95% CI HR 95% CI HR 95% CI HR 95% CI Pfor trend HR 95% CI
Fibre
Deaths (n) 316 323 320 302 Per 10 g
Model 1* 1·0 Ref. 0·98 0·83, 1·14 0·95 0·81, 1·11 0·89 0·76, 1·05 0·20 0·98 0·91, 1·06
Model 2† 1·0 Ref. 0·96 0·81, 1·14 0·93 0·77, 1·12 0·84 0·66, 1·06 0·57 0·95 0·84, 1·08
Red and processed meat
Deaths (n) 331 300 309 321 Per 50 g
Model 1* 1·0 Ref. 0·92 0·78, 1·03 0·96 0·82, 1·13 1·04 0·88, 1·22 0·99 1·02 0·91, 1·15
Model 2† 1·0 Ref. 0·91 0·77, 1·07 0·94 0·79, 1·11 1·00 0·83, 1·20 0·38 1·01 0·88, 1·16
Red meat
Deaths (n) 319 319 293 330 Per 40 g
Model 1* 1·0 Ref. 1·01 0·86, 1·18 0·85 0·72, 1·01 0·94 0·79, 1·13 0·22 0·97 0·90, 1·06
Model 2† 1·0 Ref. 1·01 0·86, 1·18 0·87 0·73, 1·04 0·95 0·78, 1·14 0·47 0·98 0·90, 1·07
Processed meat
Deaths (n) 326 316 306 313 Per 30 g
Model 1* 1·0 Ref. 1·05 0·90, 1·24 1·10 0·93, 1·29 1·23 1·04, 1·46 0·14 1·03 0·99, 1·07
Model 2† 1·0 Ref. 0·98 0·83, 1·15 1·04 0·88, 1·24 1·17 0·97, 1·42 0·20 1·02 0·98, 1·07
Poultry
Deaths (n) 330 322 303 306 Per 20 g
Model 1* 1·0 Ref. 0·95 0·81, 1·11 1·02 0·86, 1·20 0·91 0·77, 1·07 0·44 0·96 0·91, 1·02
Model 2† 1·0 Ref. 0·91 0·77, 1·07 0·99 0·83, 1·16 0·87 0·73, 1·03 0·35 0·96 0·90, 1·02
Q, quartile; Ref., referent values; M, men; W, women.
* Model 1: adjusted for age at diagnosis (1-year increments) and sex; stratified by country.
† Model 2: adjusted for age at diagnosis (1-year increments), sex, BMI (continuous), smoking status (current, former, never, unknown), tumour grade (well differentiated, moderately
differentiated, poorly/undifferentiated, unknown), tumour stage (I, II, III, IV, unknown), year of tumour diagnosis (continuous), energy intake (kJ/d (kcal/d)), Ca intake (mg/d), folate
intake (mg/d), alcohol intake (g/d: 0, >0–6 (M)/>0–3 (W), >6–12 (M)/>3–12 (W), >12–24, >24–60, >60), and education (primary school, technical/professional school, secondary
school, longer education (including university, unknown)); stratified by country.
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Index (A-HEI)-2010 was associated with lower mortality, but
found no association for the DASH (Dietary Approaches to Stop
Hypertension), Alternate Med Score, ‘Western’ pattern or
‘Prudent’ pattern(31). Among the individual components of the
A-HEI, a signiﬁcant association with all-cause mortality was
found only for greater post-diagnostic consumption of sugar-
sweetened beverages (SSB)(31). SSB also contributed to the
data-derived patterns associated with poorer CRC survival
outcomes in studies from Canada(33) and the USA(32). In an
earlier analysis of CRC survival in EPIC, SSB were included in an
index based on pre-diagnostic adherence to World Cancer
Research Fund/American Institute for Cancer Research (WCRF/
AICR) cancer prevention recommendations; greater adherence
to the recommendations was associated with improved CRC
survival(34). However, exclusion of SSB from the index did not
attenuate the protective effect of higher WCRF/AICR scores
among CRC survivors(34), and thus it is unlikely that the null
results of the present analysis can be explained by a failure to
account for SSB intake. In contrast to the present results, an
inverse association was detected between the pre-diagnostic
plant product component of the WCRF/AICR score and CRC-
speciﬁc mortality; however, for the animal products compo-
nent, results were similarly non-signiﬁcant(34). Overall, the
interpretation of index components remains complex; in one
study, the pre-diagnostic red and processed meat pattern
associated with poorer CRC survival included ﬁsh as a
component(33), which has previously been associated with
lower risk of CRC incidence(35).
It is thought that cancer recurrence can be partly attributed to
proliferation of micrometastatic disease that was not removed at
the time of surgery. Accordingly, it is possible that some dietary
factors associated with the development and progression of
incident CRC tumours may also be associated with recurrence;
one of the mechanisms by which diet could be related to
CRC survival outcomes is through modiﬁcation of circulating
insulin levels, which is positively associated with greater
production of insulin-like growth factor (IGF)-1(36). For exam-
ple, ‘prudent’ dietary patterns (characterised by higher intake
of fruits, vegetables, poultry, ﬁsh, whole grains and legumes)
have been associated with lower levels of insulin, whereas
‘Western’ dietary patterns (characterised by higher intakes of
red meat, processed meat, French fries, eggs, high-fat dairy
products, sweets and reﬁned grains) were positively associated
with insulin and C-peptide levels(37). Evidence from animal
models indicates that greater IGF-1 exposure is associated
with an increased rate of tumour progression(38). In human
studies, the results are more complex: there was no associa-
tion between post-diagnostic IGF-1 levels and overall
survival, but post-diagnostic insulin-like growth factor binding
protein 3 (IGFBP-3) was inversely associated with tumour
progression(39). In addition, a diet high in ﬁbre can result in
higher levels of SCFA in the lumen, which can serve to induce
apoptosis in tumour cells(40).
Despite these potential pathways, we found no association
between pre-diagnostic red meat or ﬁbre intakes and CRC sur-
vival, and only marginally suggestive results for processed meat.
An implicit assumption of the present analysis is that pre-
diagnostic dietary intake is predictive of post-diagnostic diet. It is
plausible that for some participants surgical treatment of CRC
results in complications that require temporary or permanent
dietary adjustments to avoid intestinal discomfort. A study on
CRC survivors reported that, although the majority of respon-
dents resumed comfort with their diet within 12 months, avoid-
ance of foods such as fruits and vegetables was higher among
those with a permanent ostomy (surgically created opening in
the body for the discharge of body waste, 9·1%) v. those who
had their ostomy reversed (3·6%)(41). In contrast, a comparison
of repeat dietary assessments in a cohort of Norwegian women
yielded no differences in consumption of ﬁbre, red meat or
poultry between the pre-and post-diagnostic period among CRC
survivors(42). Intake of total meat products was lower during the
post-diagnostic dietary assessment among the Norwegian CRC
survivors, but the change was comparable with that observed in
cancer-free women in the cohort(42). In principle, studies with
the greatest potential to inﬂuence the development of cancer
survival recommendations would be those with multiple dietary
assessments both before and after diagnosis. Some of the
aforementioned limitations may be addressed in the future by a
multistage CRC survival-speciﬁc cohort that is underway at pre-
sent(43). In the interim, the present analysis contributes to limited
literature on diet and CRC survival.
The design of the present study had a number of strengths in
terms of capacity to examine CRC survival. The collection of
pre-diagnostic dietary data avoided the issue dietary variability
close to the time of diagnosis, and thus avoided reverse
causality, and standardised dietary assessment was undertaken.
A range of sensitivity analyses was undertaken, including the
exclusion of early mortality events, advanced stage tumours and
stratiﬁcation by duration since dietary assessment. The sample
size was large, and there were data on a wide range of
potentially confounding covariates including general and
abdominal obesity (BMI and waist circumference), Ca, folate
and alcohol intakes, and smoking status.
In conclusion, we found no evidence of an association
between pre-diagnostic intakes of red meat or ﬁbre and CRC
survival. There is suggestive evidence of an association
between poultry intake and all-cause mortality among female
CRC survivors, and between processed meat intake and CRC-
speciﬁc mortality; however, further research using post-
diagnostic dietary data is required to conﬁrm this relationship.
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